Doo‐Il Kim

6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial

Joo‐Yong Hahn, Young Bin Song, Ju Hyeon Oh et al. · The Lancet · 2018 · 366 citations

Medicine, Cardiology, Pharmacotherapy +17

Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial

Bon‐Kwon Koo, Jeehoon Kang, Kyung Woo Park et al. · The Lancet · 2021 · 353 citations

Medicine, Cardiology, Pharmacotherapy +15

Characterization of diverse natural variants of CYP102A1 found within a species of Bacillus megaterium

Ji‐Yeon Kang, So Young Kim, Doo‐Il Kim et al. · AMB Express · 2011 · 255 citations · Full text

Life Sciences, Biochemistry, Microbiology +13

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Deepak L. Bhatt, Philippe Gabríel Steg, Shamir R Mehta et al. · The Lancet · 2019 · 210 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Biosynthesis of the Allylmalonyl-CoA Extender Unit for the FK506 Polyketide Synthase Proceeds through a Dedicated Polyketide Synthase and Facilitates the Mutasynthesis of Analogues

SangJoon Mo, Dong‐Hwan Kim, Jong Hyun Lee et al. · Journal of the American Chemical Society · 2010 · 165 citations

Life Sciences, Biochemistry, Molecular Biology +13